Enovis Corp (ENOV) — Technical state
As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Signal: Recovery attempt under the 200-day — Trades +40.8% vs the 50-day and +21.9% vs the 200-day average, 12.9% below the 52-week high and +69% off the 52-week low; a death cross printed 33 sessions ago. Computed from daily closes. (as of 2026-11-10)
- Trend: Enovis Corp trades 40.8% above its 50-day and 21.9% above its 200-day moving average. (as of 2026-11-10)
Enovis makes medical devices for bone and joint care, split into two segments. The Prevention and Recovery unit sells braces, hot and cold therapies, bone-growth stimulators, compression garments and physical-therapy tools used by clinicians and physiotherapists.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ENOV overview. Research diary readings, not advice.
Trades +40.8% vs the 50-day and +21.9% vs the 200-day average, 12.9% below the 52-week high and +69% off the 52-week low; a death cross printed 33 sessions ago. Computed from daily closes.
The moving-average stack
- vs 20-day+26.2%
- vs 50-day+40.8%
- vs 200-day+21.9%
- 52-week band12.9% off the high · +69% off the low
- Streak1 consecutive down session
- CrossoverDeath cross 33 sessions ago
- 50-day crossprice crossed up through the 50-day 6 sessions ago
- Stochastic%K 83.4 · %D 82.4 · bull cross
Continue: the ENOV chart & overview · the signal board
FAQ · from the current data · as of 2026-11-10
Quick answers
What is the current Closelooknet signal on ENOV?
Recovery attempt under the 200-day — Trades +40.8% vs the 50-day and +21.9% vs the 200-day average, 12.9% below the 52-week high and +69% off the 52-week low; a death cross printed 33 sessions ago. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is ENOV above its 50-day and 200-day moving averages?
As of 2026-11-10, Enovis Corp trades +40.8% above its 50-day and +21.9% above its 200-day average, with the 20-day +26.2% away.
How far is ENOV from its 52-week high?
12.9% below the 52-week high and 69% above the 52-week low, as of 2026-11-10.
Related in the Closelooknet universe
then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- DXCM DexCom Incindustry
- GMED Globus Medicalindustry
- SECT-B.ST Sectra AB (publ)industry
- SNN Smith & Nephew SNATS Incindustry
- SOON.SW Sonova H Agindustry
- GKOS Glaukos Corpindustry
- MED.SW Medartis Holding AGindustry
- AXGN Axogen Incindustry
- PRCT Procept Biorobotics Corpindustry
- PHG Koninklijke Philips NV ADRindustry
- CEVI.ST CellaVision ABindustry
- EW Edwards Lifesciences Corpindustry
- STE STERIS plcindustry
- QSI QuantumSi Incindustry
- LIVN LivaNova PLCindustry
- PACB Pacific Biosciences of Californiaindustry
- ZBH Zimmer Biomet Holdings Incindustry
- DEMANT.CO Demant A/Sindustry
- MDT Medtronic PLCindustry
- HAE Haemonetics Corporationindustry